Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis
- PMID: 865079
Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosis
Abstract
An experimental model of focal sclerosis (FS) following chronic administration of aminonucleoside (AMNS) is described in rats with pathologic features similar to those observed in human steroid-resistant idiopathic nephrotic syndrome. Six groups of rats were given intraperitoneal injections of either 0.9% normal saline or aminonucleoside (13 mg. per 100 gm. of body weight); four groups underwent a right nephrectomy on day 22; a second series of injections of saline or aminonucleoside were then administered to all six groups: group I (five animals), saline-saline; group II (10 animals), AMNS-AMNS; group III (10 animals), AMNS-nephrectomy-AMNS; group IV (five animals), AMNS-nephrectomy-saline; group V (five animals), saline-nephrectomy-AMNS; group VI (five animals), saline-nephrectomy-saline. A relationship between the percentage of glomeruli with focal sclerosis and the total amount of protein excreted during the course of the experiment was observed (r=0.80). An apparent threshold level of protein excretion essential for the development of FS was also noted in that all rats excreting greater than 2.2 integral units developed FS whereas those excreting less than this amount did not. The highest incidence of FS was seen in rats that had received AMNS after unilateral nephrectomy: 62% of glomeruli with FS in group III and 26% in group V; whereas no FS was seen in groups I and VI or in rats evaluated 7 to 23 days after a single injection of AMNS. These studies indicate a quantitative relationship between the breakdown in the permeability barrier to protein and the ultimate development of FS. The prior demonstration of epithelial cell alteration in acute AMNS disease and the morphologic changes presented in this and the subsequent paper (Velosa JA, Glasser RJ, Nevins TE, Michael AF: Lab Invest 36:527, 1977) support the concept that irreversible epithelial cell injury may be the primary event in the development of FS.
Similar articles
-
Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.Lab Invest. 1984 Sep;51(3):277-85. Lab Invest. 1984. PMID: 6471809
-
Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.J Lab Clin Med. 1975 May;85(5):756-68. J Lab Clin Med. 1975. PMID: 1091713
-
Experimental model of focal sclerosis. II. Correlation with immunopathologic changes, macromolecular kinetics, and polyanion loss.Lab Invest. 1977 May;36(5):527-34. Lab Invest. 1977. PMID: 865080 No abstract available.
-
Focal glomerular hyalinosis and sclerosis in aminonucleoside and adriamycin nephrosis: pathogenetic and therapeutic considerations.Contrib Nephrol. 1988;60:73-82. doi: 10.1159/000414792. Contrib Nephrol. 1988. PMID: 3278860 Review. No abstract available.
-
Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy.Kidney Int. 1990 Feb;37(2):749-57. doi: 10.1038/ki.1990.42. Kidney Int. 1990. PMID: 2407887 Review.
Cited by
-
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.J Clin Invest. 1984 May;73(5):1448-61. doi: 10.1172/JCI111349. J Clin Invest. 1984. PMID: 6715546 Free PMC article.
-
Glomerular response to immunologic injury, studies on progression.Springer Semin Immunopathol. 1982;5(3):297-320. doi: 10.1007/BF01892090. Springer Semin Immunopathol. 1982. PMID: 6191400 Review. No abstract available.
-
Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.J Clin Invest. 1988 Jul;82(1):322-30. doi: 10.1172/JCI113590. J Clin Invest. 1988. PMID: 3392211 Free PMC article.
-
Co-Culture of Glomerular Endothelial Cells and Podocytes in a Custom-Designed Glomerulus-on-a-Chip Model Improves the Filtration Barrier Integrity and Affects the Glomerular Cell Phenotype.Biosensors (Basel). 2023 Mar 3;13(3):339. doi: 10.3390/bios13030339. Biosensors (Basel). 2023. PMID: 36979551 Free PMC article.
-
Characterizing Glomerular Barrier Dysfunction with Patient-Derived Serum in Glomerulus-on-a-Chip Models: Unveiling New Insights into Glomerulonephritis.Int J Mol Sci. 2024 May 8;25(10):5121. doi: 10.3390/ijms25105121. Int J Mol Sci. 2024. PMID: 38791159 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous